National Comprehensive Cancer Network



About NCCN

Non-Hodgkin`s Lymphomas Panel - Disclosures as of 6/14/2010

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Attendance

Jeremy S. Abramson, MD

None

None

None

None

None

Ranjana H. Advani, MD

None

Allos

None

None

None

C. Babis Andreadis, MD, MSCE

None

Allos

None

None

None

Nancy Bartlett, MD

None

None

None

None

None

John C. Byrd, MD

None

None

None

None

None

Myron S. Czuczman, MD

None

Abbott Laboratories;
Amgen Inc.;
Biogen Idec;
Celgene Corporation;
Cephalon, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

Mary Dwyer, MS

None

None

None

None

None

Luis E. Fayad, MD

Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Wyeth Pharmaceuticals

Cell Therapeutics, Inc.;
Cephalon, Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Wyeth Pharmaceuticals

None

None

None

Andres Forero, MD

Biogen Idec;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Martha J. Glenn, MD

None

None

None

None

None

Jon P. Gockerman, MD

None

None

None

None

None

Leo I. Gordon, MD

None

CureTech Ltd.

None

CureTech Ltd.

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Nancy Lee Harris, MD

None

None

None

None

None

Richard T. Hoppe, MD

None

None

None

None

None

Steven M. Horwitz, MD

None

Celgene Corporation;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
allos;
gloucester;
Seattle Genetics

None

None

None

Youn H. Kim, MD

None

Eisai Inc.;
Merck & Co., Inc.;
Gloucester;
Therakos, Inc.

None

None

None

Ann S. LaCasce, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Auayporn Nademanee, MD

None

Allos Company

None

None

None

Pierluigi Porcu, MD

None

Therakos, Inc.

None

None

None

Oliver Press, MD, PhD

None

Genentech, Inc.;
Roche Laboratories, Inc.

None

None

None

Leonard R. Prosnitz, MD

None

None

None

None

None

Nishitha Reddy, MD

None

None

None

None

None

Lubomir Sokol, MD, PhD

None

Eisai Inc.;
Eisai Inc.;
Allos;
Gloucester

None

None

None

Hema Sundar, PhD

None

None

None

None

None

Lode J. Swinnen, MB, ChB

None

Abbott Laboratories;
Genentech, Inc.

None

None

None

Julie M. Vose, MD, MBA

None

None

None

None

None

William G. Wierda, MD, PhD

None

Celgene Corporation;
Cephalon, Inc.;
Genentech, Inc.;
Genzyme Corporation;
Micromet;
sanofi-aventis U.S.;
Schering-Plough Corporation

None

None

None

Joachim Yahalom, MD

None

None

None

None

None

Nadeem Zafar, MD

None

None

None

None

None

Andrew D. Zelenetz, MD, PhD

None

Bristol-Myers Squibb Company;
Cephalon, Inc.;
Eli Lilly and Company;
Genentech, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Allos;
Cancer Genetics;
sanofi-aventis U.S.

None

None

None